Resultados da pesquisa - Michael T. Nurmohamed

Refinar resultados
  1. 1
    Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022

    Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022 Por Bas Dijkshoorn, Reinder Raadsen, Michael T. Nurmohamed

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  2. 2
    Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice

    Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice Por Rabia Agca, Yvo M. Smulders, Michael T. Nurmohamed

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  3. 3
    Management and evaluation of extra-articular manifestations in spondyloarthritis

    Management and evaluation of extra-articular manifestations in spondyloarthritis Por Irene E. van der Horst‐Bruinsma, Michael T. Nurmohamed

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study

    Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study Por C. Krieckaert, Michael T. Nurmohamed, Gertjan Wolbink, Willem F. Lems

    Publicado em 2012
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    Confounding by Indication Probably Distorts the Relationship between Steroid Use and Cardiovascular Disease in Rheumatoid Arthritis: Results from a Prospective Cohort Study

    Confounding by Indication Probably Distorts the Relationship between Steroid Use and Cardiovascular Disease in Rheumatoid Arthritis: Results from a Prospective Cohort Study Por Alper M. van Sijl, Maarten Boers, Alexandre E. Voskuyl, Michael T. Nurmohamed

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  6. 6
    Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment

    Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment Por Ernest Choy, Kandeepan Ganeshalingam, Anne Grete Semb, Zoltán Szekanecz, Michael T. Nurmohamed

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  7. 7
    Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion

    Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion Por Inge A. M. van den Oever, Alper M. van Sijl, Michael T. Nurmohamed

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis

    Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis Por Michael T. Nurmohamed, Yanjun Bao, James Signorovitch, Alex Trahey, Parvez Mulani, Diana Dan

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus

    Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus Por Inge A. M. van den Oever, Hennie G. Raterman, Michael T. Nurmohamed, Suat Şimşek

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  10. 10
    Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout

    Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout Por Romy Hansildaar, Daisy Vedder, Milad Baniaamam, Anne-Kathrin Tausche, Martijn Gerritsen, Michael T. Nurmohamed

    Publicado em 2020
    Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  11. 11
    Is atherosclerosis an autoimmune disease?

    Is atherosclerosis an autoimmune disease? Por Eiji Matsuura, Fabiola Atzeni, Piercarlo Sarzi‐Puttini, Maurizio Turiel, Luis R. Lopez, Michael T. Nurmohamed

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  12. 12
    (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis

    (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosi... Por Debby den Uyl, Michael T. Nurmohamed, L. van Tuyl, Hennie G. Raterman, Willem F. Lems

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  13. 13
    The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better

    The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better Por Matthew Peters, Alexandre E. Voskuyl, Naveed Sattar, Ben A. C. Dijkmans, Yvo M. Smulders, Michael T. Nurmohamed

    Publicado em 2010
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial

    Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial Por M. l’Ami, C. Krieckaert, Michael T. Nurmohamed, Ronald van Vollenhoven, Theo Rispens, Maarten Boers, Gertjan Wolbink

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic Review

    Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic Review Por Daisy Vedder, Wendy Walrabenstein, Maaike Heslinga, Ralph de Vries, Michael T. Nurmohamed, Dirkjan van Schaardenburg, Martijn Gerritsen

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  16. 16
    Probability of Medication Intensifications in Rheumatoid Arthritis Patients With Low Disease Activity Scores on Their Patient-Reported Outcomes

    Probability of Medication Intensifications in Rheumatoid Arthritis Patients With Low Disease Activity Scores on Their Patient-Reported Outcomes Por Bart Seppen, Simone J. Verkleij, Jimmy Wiegel, Marieke M. ter Wee, Michael T. Nurmohamed, Wouter H Bos

    Publicado em 2022
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care

    Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care Por Markus M. J. Nielen, Alper M. van Sijl, Mike J. Peters, Robert Verheij, François Schellevis, Michael T. Nurmohamed

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.

    Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Por Vokko P. van Halm, Michael T. Nurmohamed, Jos W. R. Twisk, Ben A. C. Dijkmans, Alexandre E. Voskuyl

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    Adalimumab Significantly Reduces the Recurrence Rate of Anterior Uveitis in Patients with Ankylosing Spondylitis

    Adalimumab Significantly Reduces the Recurrence Rate of Anterior Uveitis in Patients with Ankylosing Spondylitis Por J. Christiaan van Denderen, I.M. Visman, Michael T. Nurmohamed, Maria S.A. Suttorp-Schulten, Irene van der Horst‐Bruinsma

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    Residual disease activity in psoriatic arthritis: discordance between the rheumatologist’s opinion and minimal disease activity measurement

    Residual disease activity in psoriatic arthritis: discordance between the rheumatologist’s opinion and minimal disease activity measurement Por Leonieke van Mens, M. Turina, M. G. H. Van de Sande, Michael T. Nurmohamed, Arno W. R. van Kuijk, Dominique Baeten

    Publicado em 2017
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: